Investor Alert

May 5, 2022, 3:31 p.m. EDT

5 Health Care Stocks For Your May 2022 Watchlist

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Sierra Oncology Inc. (SRRA)

or Cancel Already have a watchlist? Log In

May 05, 2022 (StockMarket.com via COMTEX) -- Check Out These 5 Top Health Care Stocks In The Stock Market Today

As the Fed assured the markets that bigger rate hikes are not something it is actively considering, stock market investors breathed a sigh of relief. Nevertheless, with the ongoing headwinds in the market such as supply chain issues and a war, some investors may prefer to play it safe. Hence, defensive sectors such as the health care sector could be worth watching. After all, health care is a necessity for everyone. Hence, it will always be in demand regardless of the state of the economy.

For instance, investors could be looking at the likes of AstraZeneca ( NASDAQ: AZN ). The biopharmaceutical company last week announced its first-quarter 2022 financials which beat estimates on revenue and earnings. Impressively, the company saw its product sales rise by 51%. Elsewhere, AbbVie ( NYSE: ABBV ) recently acquired Syndesi Therapeutics for $130 million. This purchase gives AbbVie a portfolio of neurological programs that are a good fit with its pre-existing pipeline. With these exciting developments in the industry, here are some of the best health care stocks to watch in the stock market today.

Health Care Stocks To Buy [Or Sell] Now


Starting us off today, we have Moderna, a company that continues to advance programs in the field of messenger RNA (mRNA) to an enterprise with a diverse clinical portfolio of vaccines. The company also has a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation. Besides, it boasts an integrated manufacturing plant that allows for both clinical and commercial production at scale. Yesterday, Moderna reported its first-quarter earnings that blew expectations.

Jumping right in, Moderna brought in total revenues of $6.07 billion, smashing Wall Street estimates of $4.62 billion. The company sold $5.9 billion worth of its Covid vaccine in the past quarter, more than tripling the sales figure of $1.7 billion in the same period last year. As for its profits, the company reported $3.66 billion in net income for the quarter, representing a threefold increase over the $1.2 billion from last year. Accordingly, earnings per share came in at $8.58 per share, well above the estimated $5.21. All in all, given the impressive earnings, is MRNA stock a buy?

[Read More] 4 Top Oil Stocks To Watch In The Stock Market Today

CVS Health

Following that, we have the health services company, CVS Health or CVS for short. In detail, it operates through four segments, Pharmacy Services, Retail/LTC, Health Care Benefits, and Corporate/Other. What sets the company apart isn't just the services it provides, it's how it provides them. CVS believes that it can help people navigate the health care system by improving access, lowering costs, and being a trusted partner for every meaningful moment of health.

Also yesterday, CVS reported its quarterly financials that outpaced analyst expectations. For starters, it brought in total revenues of $76.83 billion, exceeding consensus forecasts of $75.39 billion and same-quarter 2021 revenues of $75.39 billion. Besides that, CVS saw its same-store sales grow by 10.7% in the past quarter. Net income, on the other hand, was $2.31 billion, or $1.74 per share. This is a rise from the $2.22 billion, or $1.68 per share in the year prior. With this solid quarter in the books, does CVS stock deserve a spot on your watchlist?

[Read More] Top Stock Market News For Today May 5, 2022


1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.